De-differentiation in thyroid cancer: an increasingly appreciated concept

Authors

  • Poolakkil Prasanth Department of Surgical Oncology, Malabar Cancer Centre, Thalassery, Kerala, India
  • Sajith Babu Thavarool Department of Surgical Oncology, Malabar Cancer Centre, Thalassery, Kerala, India
  • Satheesan Balasubramanyam Department of Surgical Oncology, Malabar Cancer Centre, Thalassery, Kerala, India
  • Kandathil Joseph Philip Department of Pathology, Malabar Cancer Centre, Thalassery, Kerala, India

DOI:

https://doi.org/10.18203/2349-2902.isj20210400

Keywords:

Thyroid cancer, Multiple histology, De-differentiation, Multifocal thyroid cancer

Abstract

Thyroid cancer is the most common endocrine malignancy. In general, they are said to be of good prognosis, still there are a few aggressive variants. Differentiated carcinomas like papillary and follicular comprise of major proportion and have a less aggressive clinical behaviour, even though some of them tend to be otherwise. De-differentiated and undifferentiated cancers are more aggressive. There has been an already existing theory that these de-differentiated cancers arise from differentiated ones by a process of stepwise molecular changes. There are already reported cases of coexistence of multiple histologies. Appreciation of dedifferentiation and identification of the genetic changes may be of help in forming improved treatment strategies, including targeted therapy. This article is to report a rare case we came across, in which three different histologies coexisted and may be pointing towards graded de-differentiation pattern. This is a further support to the stepwise de-differentiation theory.

Author Biography

Poolakkil Prasanth, Department of Surgical Oncology, Malabar Cancer Centre, Thalassery, Kerala, India

Senior Resident in Surgical Oncology

References

Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. - PubMed-NCBI. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23737785. Accessed on 20 July 2020.

Sadow PM, Faquin WC. Poorly differentiated thyroid carcinoma: An incubating entity. Front Endocrinol (Lausanne). 2012;3.

Volante M, Papotti M. Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. Endocr Pathol. 2010;21:1-6.

Tallini G. Poorly differentiated thyroid carcinoma. Are we there yet? Endocr Pathol. 2011;22(4):190–4.

Asioli S, Erickson LA, Righi A, Jin L, Volante M, Jenkins S, et al. Poorly differentiated carcinoma of the thyroid: Validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol. 2010;23(9):1269–78.

Hararah MK, Gertz RJ, Sippel RS, Wieland AM. De-differentiation of Conventional Papillary Thyroid Carcinoma into Squamous Cell Carcinoma. 2015.

Bronner MP, LiVolsi VA. Spindle cell squamous carcinoma of the thyroid: an unusual anaplastic tumor associated with tall cell papillary cancer. Mod Pathol. 1991;4(5):637–43.

Papp S, Asa SL. When Thyroid Carcinoma Goes Bad: A Morphological and Molecular Analysis. Head Neck Pathol. 2015;9(1):16–23.

Nikitski AV, Rominski SL, Condello V, Kaya C, Wankhede M, Panebianco F, et al. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma. Thyroid. 2020;29(10):1425–37.

Downloads

Published

2021-01-29

Issue

Section

Case Reports